BBH News and Press, VanEck Vectors Biotech ETF From 01/22/26

2026-01-22 13:04:02 ET More on Novartis Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Novartis: A Mispriced Hedge In A Crowded Equity Mark...

2026-01-22 11:12:42 ET More on markets Prediction markets keep Greenland in focus even as Wall Street shrugs off volatility VanEck spotlights SLB, HAL, BKR, PSX, and VLO as oil plays Apollo warns U.S. risks overheating in 2026 as growth tailwinds multiply T...

2026-01-22 06:07:00 ET By Vinay Thapar, CFA and Jane Bleeg More clarity on regulatory and policy issues can help healthcare stocks reassert their fundamental strengths. Read the full article on Seeking Alpha For further details see: Are Healthcare Stocks Pois...

2026-01-21 16:26:22 ET Investment Thesis Read the full article on Seeking Alpha For further details see: BBH: Mature Biotech Exposure, But Limited Growth Ahead

2026-01-13 06:30:00 ET Transcript We just had three years of double-digit returns for S&P 500 that is quite rare, and if we make it into four depends a lot on earnings. Q4 is starting to report, and there are three themes on my mind.... Read the full article on...

2026-01-13 01:23:28 ET Investment Thesis Read the full article on Seeking Alpha For further details see: IYH: Elevated Valuations And Slowing Growth Signal Subpar 2026 Returns

2026-01-08 13:15:11 ET More on biotech, biopharma Biotech: Time For A Pause To Start 2026 2026 Market Outlook: S&P 500 Looks Expensive, But Biotech Could Outperform Under The Hood iShares Biotechnology ETF: The M&A Wave Behind The Suddenly Booming Biotech Sec...

2026-01-08 05:30:00 ET After a prolonged slump, investors are giving the healthcare sector a second look as lower interest rates, potential M&A and even AI innovation help to improve the outlook. Jacky He, Vice President for Portfolio Research at TD Asset Management, joins MoneyTalk...

2025-12-30 08:57:41 ET Since my October article , Biogen Inc. ( BIIB ) stock has risen 18.4%, outperforming the S&P 500 [2.9% return] ( SPY ), as well as two "bellwethers" for the biotech investors, the iShares Biotechnology ETF [14%] ( IBB ) and VanEck Biotech ETF [...

2025-12-26 13:03:28 ET I last covered Amgen Inc. ( AMGN ) at the end of September, "Amgen: Imdelltra Could Be The Next Game Changer."... Read the full article on Seeking Alpha For further details see: Can Amgen Sustain Its Rally In 2026